Angela Ritter
Family Medicine · Gainesville, GANPI 1427041755
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $16,367 of the $22,552 with a category attached, or 72.6%. Eli Lilly accounts for 88.2% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2023 at $17,713 and has fallen 98.2% since, to $322 in 2025. Among family medicine clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 240 payments — averaging $93.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$20K
- Novo Nordisk$499
- Amgen$380
- AbbVie$234
- AstraZeneca$212
- Amarin Pharma, Inc.$200
- plus $1K from 22 others
Across 197 payments — averaging $81,464 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$10.4M
- Genentech, Inc.$3.6M
- Roche Diagnostics Operations, Inc.$1.7M
- Novartis$314K
- Kiniksa Pharmaceuticals, Ltd.$12K
- Integra Lifesciences Corporation$10K
What the payments were for
- Consulting fees$2,1009%
- Travel & lodging$16,36773%
- Food & beverage$4,03418%
- Education$500%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 100 | $19,880 |
| Novo Nordisk | 21 | $499 |
| Amgen | 16 | $380 |
| AbbVie(2 entities) | 14 | $234 |
| AstraZeneca | 11 | $212 |
| Amarin Pharma, Inc. | 12 | $200 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $121 |
| Boehringer Ingelheim | 7 | $112 |
| Sanofi-aventis U.S. LLC | 7 | $107 |
| Lilly USA, LLC | 8 | $89 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $86 |
| F. Hoffmann-la Roche AG | 1 | $80 |
| Merck | 6 | $77 |
| Pfizer | 5 | $75 |
| Otsuka America Pharmaceutical, Inc. | 5 | $65 |
| Kowa Pharmaceuticals America, Inc. | 4 | $58 |
| Novartis | 3 | $56 |
| Genentech, Inc. | 1 | $50 |
| Eisai Inc. | 2 | $28 |
| GSK | 2 | $24 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Endo Pharmaceuticals Inc. | 1 | $18 |
| Upsher-smith Laboratories LLC | 1 | $15 |
| Astellas Pharma US Inc | 1 | $14 |
| Johnson & Johnson | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Shire North American Group Inc | 1 | $13 |
| Genentech USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$22,552 in reported general payments places this provider in the 95th percentile of 3,111 family medicine providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diazepam | 16 | $10 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Gainesville
- Andrew ReismanGainesville$18K
- Jeffrey KingsleyColumbus$404K
- Debbie HaginsSavannah$279K
- Yolanda WadeTyrone$233K
- Julian HutchinsWarrenton$222K
- Nadine Halliburton-FosterCumming$219K
- Contessa MetcalfeAtlanta$157K
- Elmore AlexanderStone Mountain$155K
- Bantwal BaligaColumbus$115K
- Avril CampbellFort Benning$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.